Personnel Announcement
Novo Nordisk Pharma Ltd. announced personnel changes effective March 1, 2026. Ryo Kato will assume the role of Head of Medical Policy and External Affairs Division, and Junko McMaster will become the Director of the Corporate Affairs Department. These changes aim to strengthen the organizational structure.
📋 Article Processing Timeline
- 📰 Published: March 30, 2026 at 19:00
- 🔍 Collected: March 30, 2026 at 22:56 (3h 56m after Published)
- 🤖 AI Analyzed: April 21, 2026 at 13:31 (518h 35m after Collected)
Novo Nordisk Pharma Ltd. (Representative Director and President: Keisuke Kotani, Headquarters: Chiyoda-ku, Tokyo; hereinafter "Novo Nordisk Pharma") announces the following personnel changes.
**① Executive Personnel (Effective March 1, 2026)**
| Name | New Position | Old Position |
|---|---|---|
| Ryo Kato (Kato Ryo) | Head of Medical Policy and External Affairs Division | Head of Public Affairs Department, Medical Policy and External Affairs Division |
| Name | New Position | Old Position |
|---|---|---|
| Junko McMaster (McMaster Junko) | Director of Corporate Affairs Department | ― |
**About Novo Nordisk**
Novo Nordisk is a leading global healthcare company headquartered in Denmark, founded in 1923. Our purpose is to drive change and defeat serious chronic diseases, building on our knowledge and experience gained in diabetes. To achieve this goal, we strive to discover scientific innovations, expand access to medicines, and ultimately prevent and cure diseases. Novo Nordisk currently employs approximately 68,800 people in 80 countries, and its products are sold in approximately 170 countries. Novo Nordisk Pharma Ltd., the Japanese subsidiary, was established in 1980.
**① Executive Personnel (Effective March 1, 2026)**
| Name | New Position | Old Position |
|---|---|---|
| Ryo Kato (Kato Ryo) | Head of Medical Policy and External Affairs Division | Head of Public Affairs Department, Medical Policy and External Affairs Division |
| Name | New Position | Old Position |
|---|---|---|
| Junko McMaster (McMaster Junko) | Director of Corporate Affairs Department | ― |
**About Novo Nordisk**
Novo Nordisk is a leading global healthcare company headquartered in Denmark, founded in 1923. Our purpose is to drive change and defeat serious chronic diseases, building on our knowledge and experience gained in diabetes. To achieve this goal, we strive to discover scientific innovations, expand access to medicines, and ultimately prevent and cure diseases. Novo Nordisk currently employs approximately 68,800 people in 80 countries, and its products are sold in approximately 170 countries. Novo Nordisk Pharma Ltd., the Japanese subsidiary, was established in 1980.